|
DE2843963A1
(de)
*
|
1978-10-09 |
1980-04-24 |
Merck Patent Gmbh |
Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin
|
|
US4374121A
(en)
*
|
1979-09-12 |
1983-02-15 |
Seton Company |
Macromolecular biologically active collagen articles
|
|
JPS5767521A
(en)
*
|
1980-09-25 |
1982-04-24 |
Yamanouchi Pharmaceut Co Ltd |
Agent for improving circulation blood vessel
|
|
US4304765A
(en)
*
|
1980-10-14 |
1981-12-08 |
Alza Corporation |
Ocular insert housing steroid in two different therapeutic forms
|
|
US4432964A
(en)
*
|
1981-08-24 |
1984-02-21 |
Alza Corporation |
Topical composition containing steroid in two forms released independently from polymeric carrier
|
|
FR2524312B1
(fr)
*
|
1982-04-01 |
1985-10-04 |
Tech Cuir Centre |
Nouvelles formes de micro-encapsulation de substances medicamenteuses par des couches homogenes de collagene natif
|
|
US4505855A
(en)
*
|
1982-09-30 |
1985-03-19 |
Massachusetts General Hospital |
Transparent non-fibrilized collagen material by ultracentrifugation
|
|
US4478818A
(en)
*
|
1982-12-27 |
1984-10-23 |
Alza Corporation |
Ocular preparation housing steroid in two different therapeutic forms
|
|
GB8306353D0
(en)
*
|
1983-03-08 |
1983-04-13 |
Stuart J F B |
Monitoring of drug levels
|
|
JPS6025920A
(ja)
*
|
1983-07-22 |
1985-02-08 |
Japan Atom Energy Res Inst |
薬物含有徐放性複合体及びその調製方法
|
|
JPS6028936A
(ja)
*
|
1983-07-27 |
1985-02-14 |
Koken:Kk |
アテロコラ−ゲン水溶液およびその製造方法
|
|
JPS6084213A
(ja)
*
|
1983-10-14 |
1985-05-13 |
Sumitomo Chem Co Ltd |
徐放性消炎鎮痛製剤
|
|
JPS6089418A
(ja)
*
|
1983-10-20 |
1985-05-20 |
Sumitomo Chem Co Ltd |
徐放性制癌剤
|
|
US4563184A
(en)
*
|
1983-10-17 |
1986-01-07 |
Bernard Korol |
Synthetic resin wound dressing and method of treatment using same
|
|
FR2559780B1
(fr)
*
|
1984-02-21 |
1990-05-04 |
Tech Cuir Centre |
Systemes biocompatibles implantables a base de collagene permettant la conservation et/ou la culture cellulaires et/ou la liberation controlee de principes actifs
|
|
US4748152A
(en)
*
|
1985-01-22 |
1988-05-31 |
Opticol Corp. |
Succinylated atelocollagen solution for use in viscosurgery and as a vitreous substitute
|
|
US4713446A
(en)
*
|
1985-09-06 |
1987-12-15 |
Minnesota Mining And Manufacturing Company |
Viscoelastic collagen solution for ophthalmic use and method of preparation
|
|
US4851513A
(en)
*
|
1985-09-06 |
1989-07-25 |
Minnesota Mining And Manufacturing Company |
Viscoelastic collagen solution for opthalmic use and method of preparation
|
|
US4883864A
(en)
*
|
1985-09-06 |
1989-11-28 |
Minnesota Mining And Manufacturing Company |
Modified collagen compound and method of preparation
|
|
DE3688188T2
(de)
*
|
1985-12-27 |
1993-10-14 |
Koken Kk |
Verfahren zur Herstellung einer Formulierung mit verzögerter Freisetzung.
|
|
FR2601371B1
(fr)
*
|
1986-07-11 |
1989-05-12 |
Merieux Inst |
Procede de traitement du collagene en vue, notamment, d'en faciliter la reticulation et collagene obtenu par application dudit procede
|
|
US5128134A
(en)
*
|
1986-09-17 |
1992-07-07 |
Fyodorov Svyatoslav N |
Ophthalmological collagen coverings
|
|
US5989579A
(en)
*
|
1986-10-02 |
1999-11-23 |
Escalon Medical Corp. |
Ocular insert with anchoring protrusions
|
|
US5147647A
(en)
*
|
1986-10-02 |
1992-09-15 |
Sohrab Darougar |
Ocular insert for the fornix
|
|
US5322691A
(en)
*
|
1986-10-02 |
1994-06-21 |
Sohrab Darougar |
Ocular insert with anchoring protrusions
|
|
US5094855A
(en)
*
|
1986-10-13 |
1992-03-10 |
Moskovsky Nauchno-Teknichesky Compleks "Mikrochirurgija Glaza" |
Opthalmological collagen coverings
|
|
CA1338839C
(en)
*
|
1988-01-29 |
1997-01-14 |
Yoshio Sasaki |
Controlled release formulation
|
|
US4969912A
(en)
*
|
1988-02-18 |
1990-11-13 |
Kelman Charles D |
Human collagen processing and autoimplant use
|
|
EP0403650B1
(de)
*
|
1988-03-09 |
1994-05-25 |
Terumo Kabushiki Kaisha |
Für zellen eindringbares medizinisches material und kunsthaut
|
|
US4882150A
(en)
*
|
1988-06-03 |
1989-11-21 |
Kaufman Herbert E |
Drug delivery system
|
|
US4865846A
(en)
*
|
1988-06-03 |
1989-09-12 |
Kaufman Herbert E |
Drug delivery system
|
|
US4923699A
(en)
*
|
1988-06-03 |
1990-05-08 |
Kaufman Herbert E |
Eye treatment suspension
|
|
US4923700A
(en)
*
|
1988-06-03 |
1990-05-08 |
Kaufman Herbert E |
Artificial tear suspension
|
|
US5936035A
(en)
*
|
1988-11-21 |
1999-08-10 |
Cohesion Technologies, Inc. |
Biocompatible adhesive compositions
|
|
US5800541A
(en)
*
|
1988-11-21 |
1998-09-01 |
Collagen Corporation |
Collagen-synthetic polymer matrices prepared using a multiple step reaction
|
|
US5565519A
(en)
*
|
1988-11-21 |
1996-10-15 |
Collagen Corporation |
Clear, chemically modified collagen-synthetic polymer conjugates for ophthalmic applications
|
|
US5475052A
(en)
*
|
1988-11-21 |
1995-12-12 |
Collagen Corporation |
Collagen-synthetic polymer matrices prepared using a multiple step reaction
|
|
US4946450A
(en)
*
|
1989-04-18 |
1990-08-07 |
Biosource Genetics Corporation |
Glucan/collagen therapeutic eye shields
|
|
US4978352A
(en)
*
|
1989-06-07 |
1990-12-18 |
Fedorov Svjatoslav N |
Process for producing collagen-based cross-linked biopolymer, an implant from said biopolymer, method for producing said implant, and method for hermetization of corneal or scleral wounds involved in eye injuries, using said implant
|
|
US5138030A
(en)
*
|
1989-10-10 |
1992-08-11 |
Pachence James M |
Process for extracting type I collagen form an avian source, and applications therefor
|
|
JPH03121203U
(de)
*
|
1990-03-27 |
1991-12-12 |
|
|
|
US5103840A
(en)
*
|
1990-05-07 |
1992-04-14 |
Kavoussi Harold P |
Viscoelastic collagen gel for ophthalmic surgery
|
|
US5322648A
(en)
*
|
1991-08-26 |
1994-06-21 |
Vitaphore Corporation |
Process for forming shaped collagen devices
|
|
US5259998A
(en)
*
|
1991-10-04 |
1993-11-09 |
Chiron Ophthalmics, Inc. |
Method for casting dissolvable ophthalmic shields in a mold
|
|
CA2140053C
(en)
*
|
1994-02-09 |
2000-04-04 |
Joel S. Rosenblatt |
Collagen-based injectable drug delivery system and its use
|
|
US5466233A
(en)
*
|
1994-04-25 |
1995-11-14 |
Escalon Ophthalmics, Inc. |
Tack for intraocular drug delivery and method for inserting and removing same
|
|
DE4414755C2
(de)
*
|
1994-04-27 |
2000-11-16 |
Lohmann Therapie Syst Lts |
Kollagenzubereitung zur gesteuerten Abgabe von Wirkstoffen, Verfahren und Verwendung
|
|
US5928667A
(en)
*
|
1994-06-24 |
1999-07-27 |
University Of Maryland |
Drug delivery device and method for employing the same
|
|
EP0713707A1
(de)
|
1994-11-23 |
1996-05-29 |
Collagen Corporation |
Injizierbare, in Situ vernetzbare Kollagenszusammensetzung für die Weichgewebevermehrung
|
|
US5518732A
(en)
*
|
1995-02-14 |
1996-05-21 |
Chiron Vision, Inc. |
Bio-erodible ophthalmic shield
|
|
CA2214088A1
(en)
*
|
1995-03-03 |
1996-09-12 |
Metabolex Inc. |
Novel encapsulation process by a gelling polymer
|
|
US5916790A
(en)
*
|
1995-03-03 |
1999-06-29 |
Metabolex, Inc. |
Encapsulation compositions, and methods
|
|
DE19549506C2
(de)
*
|
1995-03-07 |
1998-07-30 |
Richard Prof Dr Sueverkruep |
Darreichungsform zur äußerlichen Applikation und Verfahren zur Herstellung derselben
|
|
US6962979B1
(en)
|
1995-03-14 |
2005-11-08 |
Cohesion Technologies, Inc. |
Crosslinkable biomaterial compositions containing hydrophobic and hydrophilic crosslinking agents
|
|
US5788959A
(en)
*
|
1995-04-24 |
1998-08-04 |
University Of Maryland, Baltimore County |
Drug delivery device and method for employing the same
|
|
US5677284A
(en)
*
|
1995-06-06 |
1997-10-14 |
Regen Biologics, Inc. |
Charged collagen particle-based delivery matrix
|
|
WO1997022371A1
(en)
|
1995-12-18 |
1997-06-26 |
Collagen Corporation |
Crosslinked polymer compositions and methods for their use
|
|
US6458889B1
(en)
|
1995-12-18 |
2002-10-01 |
Cohesion Technologies, Inc. |
Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
|
|
US6833408B2
(en)
|
1995-12-18 |
2004-12-21 |
Cohesion Technologies, Inc. |
Methods for tissue repair using adhesive materials
|
|
US7883693B2
(en)
|
1995-12-18 |
2011-02-08 |
Angiodevice International Gmbh |
Compositions and systems for forming crosslinked biomaterials and methods of preparation of use
|
|
JP3935938B2
(ja)
*
|
1996-01-05 |
2007-06-27 |
オートイミューン インク |
▲ｉｉ▼型コラーゲンの調製法
|
|
US6299895B1
(en)
|
1997-03-24 |
2001-10-09 |
Neurotech S.A. |
Device and method for treating ophthalmic diseases
|
|
US7435425B2
(en)
*
|
2001-07-17 |
2008-10-14 |
Baxter International, Inc. |
Dry hemostatic compositions and methods for their preparation
|
|
US6066325A
(en)
|
1996-08-27 |
2000-05-23 |
Fusion Medical Technologies, Inc. |
Fragmented polymeric compositions and methods for their use
|
|
US8303981B2
(en)
|
1996-08-27 |
2012-11-06 |
Baxter International Inc. |
Fragmented polymeric compositions and methods for their use
|
|
US8603511B2
(en)
|
1996-08-27 |
2013-12-10 |
Baxter International, Inc. |
Fragmented polymeric compositions and methods for their use
|
|
US6083522A
(en)
*
|
1997-01-09 |
2000-07-04 |
Neucoll, Inc. |
Devices for tissue repair and methods for preparation and use thereof
|
|
JPH1156897A
(ja)
*
|
1997-08-18 |
1999-03-02 |
Koken Co Ltd |
コラーゲン眼科手術補助剤
|
|
US6197934B1
(en)
|
1998-05-22 |
2001-03-06 |
Collagenesis, Inc. |
Compound delivery using rapidly dissolving collagen film
|
|
WO2001013119A1
(en)
|
1999-08-17 |
2001-02-22 |
Luminex Corporation |
Encapsulation of fluorescent particles
|
|
DK1218437T3
(da)
|
1999-08-27 |
2009-10-19 |
Angiodevice Internat Gmbh |
Præparater, som danner interpenetrerende polymernetværk, til anvendelse som medicinske tætningsmidler med höj styrke
|
|
AU2002249958B2
(en)
|
2001-01-16 |
2007-11-08 |
Vascular Therapies, Inc. |
Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
|
|
EP1404297B1
(de)
|
2001-06-12 |
2011-04-27 |
The Johns Hopkins University School Of Medicine |
Reservoirvorrichtung für die intraokulare arzneimittelabgabe
|
|
US20030181371A1
(en)
*
|
2001-12-28 |
2003-09-25 |
Angiotech Pharmaceuticals, Inc. |
Compositions and methods of using collajolie
|
|
JP4619789B2
(ja)
*
|
2002-10-04 |
2011-01-26 |
ナノマトリックス，インコーポレイテッド |
皮膚およびその他の組織のためのシーラント
|
|
US20050013845A1
(en)
*
|
2002-11-12 |
2005-01-20 |
Warren Stephen L. |
Adhesive bioerodible ocular drug delivery system
|
|
AU2003300076C1
(en)
|
2002-12-30 |
2010-03-04 |
Angiotech International Ag |
Drug delivery from rapid gelling polymer composition
|
|
AU2003303513A1
(en)
*
|
2002-12-30 |
2004-07-29 |
Angiotech International Ag |
Tissue reactive compounds and compositions and uses thereof
|
|
US8834864B2
(en)
*
|
2003-06-05 |
2014-09-16 |
Baxter International Inc. |
Methods for repairing and regenerating human dura mater
|
|
AU2004249233A1
(en)
|
2003-06-19 |
2004-12-29 |
Vascular Therapies Llc |
Medical devices and methods for regulating the tissue response to vascular closure devices
|
|
US7927626B2
(en)
*
|
2003-08-07 |
2011-04-19 |
Ethicon, Inc. |
Process of making flowable hemostatic compositions and devices containing such compositions
|
|
EP1658109B1
(de)
*
|
2003-08-26 |
2014-01-22 |
Vista Scientific LLC |
Okulare arzneimittelzufuhreinrichtung
|
|
CN104174071A
(zh)
|
2004-04-28 |
2014-12-03 |
安希奥设备国际有限责任公司 |
用于形成交联生物材料的组合物和系统及关联的制备方法与用途
|
|
EP1796602A4
(de)
|
2004-09-17 |
2016-10-19 |
Angiotech Pharm Inc |
Multifunktionelle verbindungen zur erzeugung vernetzter biomaterialien sowie herstellungs- und verwendungsverfahren dafür
|
|
MX2007003789A
(es)
*
|
2004-10-04 |
2007-07-20 |
Qlt Usa Inc |
Suministro ocular de formulaciones polimericas para suministro.
|
|
US8313763B2
(en)
*
|
2004-10-04 |
2012-11-20 |
Tolmar Therapeutics, Inc. |
Sustained delivery formulations of rapamycin compounds
|
|
JP2008531726A
(ja)
|
2005-03-04 |
2008-08-14 |
ニューロシステック コーポレイション |
改良されたガシクリジン製剤
|
|
US20090028957A1
(en)
*
|
2005-04-19 |
2009-01-29 |
Daniloff George Y |
Implantable Tissue-Reactive Biomaterial Compositions and Systems, and Methods of Us Thereof
|
|
US20060247776A1
(en)
*
|
2005-05-02 |
2006-11-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Systems and methods for augmenting intervertebral discs
|
|
US20070005140A1
(en)
*
|
2005-06-29 |
2007-01-04 |
Kim Daniel H |
Fabrication and use of biocompatible materials for treating and repairing herniated spinal discs
|
|
US20070233252A1
(en)
*
|
2006-02-23 |
2007-10-04 |
Kim Daniel H |
Devices, systems and methods for treating intervertebral discs
|
|
SG170816A1
(en)
|
2006-03-31 |
2011-05-30 |
Qlt Plug Delivery Inc |
Drug delivery methods, structures, and compositions for nasolacrimal system
|
|
MX2008014847A
(es)
*
|
2006-05-31 |
2009-04-30 |
Baxter Int |
Metodo para crecimiento interno en la celula dirigido y regeneracion controlada de los tejidos en la cirugia espinal.
|
|
US7803148B2
(en)
*
|
2006-06-09 |
2010-09-28 |
Neurosystec Corporation |
Flow-induced delivery from a drug mass
|
|
TWI436793B
(zh)
*
|
2006-08-02 |
2014-05-11 |
巴克斯特國際公司 |
快速作用之乾密封膠及其使用和製造方法
|
|
WO2008035376A2
(en)
*
|
2006-09-19 |
2008-03-27 |
Council Of Scientific & Industrial Research |
A novel bio-erodible insert for ophthalmic applications and a process for the preparation thereof
|
|
US20090054984A1
(en)
|
2007-08-20 |
2009-02-26 |
Histogenics Corporation |
Method For Use Of A Double-Structured Tissue Implant For Treatment Of Tissue Defects
|
|
US8685107B2
(en)
|
2007-07-03 |
2014-04-01 |
Histogenics Corporation |
Double-structured tissue implant and a method for preparation and use thereof
|
|
ES2662647T3
(es)
|
2007-10-30 |
2018-04-09 |
Baxter International Inc. |
Uso de una biomatriz de colágeno biofuncional regenerativa para tratar defectos viscerales o parietales
|
|
EP2238163A1
(de)
*
|
2008-01-31 |
2010-10-13 |
Sofradim Production |
Herstellung von endgültig sterilisiertem und bei neutralem ph-wert löslichem collagen
|
|
CA2716872C
(en)
|
2008-02-29 |
2015-02-10 |
Ferrosan Medical Devices A/S |
Device for promotion of hemostasis and/or wound healing
|
|
AU2010208046B2
(en)
|
2009-01-29 |
2014-10-02 |
Forsight Vision4, Inc. |
Posterior segment drug delivery
|
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
WO2010101758A1
(en)
*
|
2009-03-03 |
2010-09-10 |
Alcon Research, Ltd. |
Peri-corneal drug delivery device
|
|
US9039783B2
(en)
*
|
2009-05-18 |
2015-05-26 |
Baxter International, Inc. |
Method for the improvement of mesh implant biocompatibility
|
|
HRP20150255T1
(hr)
*
|
2009-06-16 |
2015-05-08 |
Baxter International Inc. |
Hemostatiäśna spužva
|
|
CN105037355B
(zh)
|
2009-08-10 |
2017-06-06 |
萨穆梅德有限公司 |
Wnt信号传导途径的吲唑抑制剂及其治疗用途
|
|
NZ599399A
(en)
*
|
2009-10-07 |
2014-05-30 |
Kerecis Ehf |
A scaffold material for wound care and/or other tissue healing applications
|
|
JP2013507373A
(ja)
*
|
2009-10-08 |
2013-03-04 |
ニューロテック ユーエスエー， インコーポレイテッド |
被包された細胞ベースの送達系におけるｐｅｄｆの使用
|
|
US8771258B2
(en)
*
|
2009-12-16 |
2014-07-08 |
Baxter International Inc. |
Hemostatic sponge
|
|
LT3001903T
(lt)
|
2009-12-21 |
2018-01-10 |
Samumed, Llc |
1h-pirazolo[3,4-b]piridinai ir jų terapinis panaudojimas
|
|
US8469934B2
(en)
*
|
2010-01-27 |
2013-06-25 |
Alcon Research, Ltd. |
Pulsatile peri-corneal drug delivery device
|
|
WO2013022801A1
(en)
|
2011-08-05 |
2013-02-14 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
|
SA111320355B1
(ar)
|
2010-04-07 |
2015-01-08 |
Baxter Heathcare S A |
إسفنجة لايقاف النزف
|
|
JP5973997B2
(ja)
|
2010-06-01 |
2016-08-23 |
バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ |
乾燥した安定な止血用組成物を作製するためのプロセス
|
|
AU2011260260B2
(en)
|
2010-06-01 |
2015-09-03 |
Baxter Healthcare S.A. |
Process for making dry and stable hemostatic compositions
|
|
ES2682302T3
(es)
|
2010-06-01 |
2018-09-19 |
Baxter International Inc |
Proceso para la producción de composiciones hemostáticas secas y estables
|
|
SG187664A1
(en)
*
|
2010-08-02 |
2013-03-28 |
Euclid Systems Corp |
Collagen-based implants for sustained delivery of drugs
|
|
CN103209664A
(zh)
|
2010-08-05 |
2013-07-17 |
弗赛特影像4股份有限公司 |
可植入的治疗装置
|
|
EP3861969A1
(de)
|
2010-08-05 |
2021-08-11 |
ForSight Vision4, Inc. |
Injektorvorrichtung zur arzneimittelabgabe
|
|
AU2011285548B2
(en)
|
2010-08-05 |
2014-02-06 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
|
RU2592694C2
(ru)
|
2010-08-18 |
2016-07-27 |
СЭМЬЮМЕД, ЭлЭлСи |
Дикетоны и гидроксикетоны в качестве активатора сигнального пути катенина
|
|
WO2012068549A2
(en)
|
2010-11-19 |
2012-05-24 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
|
WO2012071559A2
(en)
|
2010-11-23 |
2012-05-31 |
Presage Biosciences, Inc. |
Therapeutic methods and compositions for solid delivery
|
|
US10398592B2
(en)
|
2011-06-28 |
2019-09-03 |
Forsight Vision4, Inc. |
Diagnostic methods and apparatus
|
|
US9102105B2
(en)
|
2011-09-13 |
2015-08-11 |
Vista Scientific Llc |
Method for forming an ocular drug delivery device
|
|
IN2014CN02646A
(de)
|
2011-09-14 |
2015-08-07 |
Samumed Llc |
|
|
PT2755600T
(pt)
|
2011-09-16 |
2021-04-19 |
Forsight Vision4 Inc |
Aparelhos de troca de fluidos
|
|
MX346958B
(es)
|
2011-10-11 |
2017-04-06 |
Baxter Int |
Composición hemostatica.
|
|
WO2013053759A2
(en)
|
2011-10-11 |
2013-04-18 |
Baxter International Inc. |
Hemostatic compositions
|
|
SG11201401878SA
(en)
|
2011-10-27 |
2014-09-26 |
Baxter Int |
Hemostatic compositions
|
|
EP2771043A4
(de)
|
2011-10-28 |
2015-04-29 |
Presage Biosciences Inc |
Wirkstofffreisetzungsverfahren
|
|
CN104159527B
(zh)
|
2012-03-06 |
2017-04-12 |
弗罗桑医疗设备公司 |
包含止血糊剂的压力容器
|
|
PH12017500997A1
(en)
|
2012-04-04 |
2018-02-19 |
Samumed Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
|
NZ629282A
(en)
|
2012-05-04 |
2017-04-28 |
Samumed Llc |
1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
|
RU2636240C2
(ru)
|
2012-06-12 |
2017-11-21 |
Ферросан Медикал Дивайсиз А/С |
Сухая гемостатическая композиция
|
|
EP2943198B1
(de)
|
2013-01-08 |
2019-07-17 |
Samumed, LLC |
3-(benzoimidazol-2-yl)-indazolinhibitoren des wnt-signalwegs und therapeutische verwendungen davon
|
|
DK2968249T3
(en)
|
2013-02-22 |
2019-03-04 |
Samumed Llc |
GAMMA DIKETONS AS WNT / BETA-CATENIN SIGNAL ROAD ACTIVATORS
|
|
WO2014152959A1
(en)
|
2013-03-14 |
2014-09-25 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
|
CN105246438B
(zh)
|
2013-03-28 |
2018-01-26 |
弗赛特影像4股份有限公司 |
用于输送治疗物质的眼科植入物
|
|
JP6390873B2
(ja)
|
2013-06-21 |
2018-09-19 |
フェッローサン メディカル ディバイス エー／エス |
減圧膨張させた乾燥組成物およびそれを保持するためのシリンジ
|
|
BR112016013322B1
(pt)
|
2013-12-11 |
2020-07-21 |
Ferrosan Medical Devices A/S |
métodos para preparação de uma composição seca e para reconstituir uma composição seca, composição seca, uso de uma composição seca, e, kit
|
|
CN106535890A
(zh)
|
2014-03-20 |
2017-03-22 |
萨穆梅德有限公司 |
5‑取代的吲唑‑3‑羧酰胺及其制备和应用
|
|
RU2017105844A
(ru)
|
2014-08-08 |
2018-09-11 |
Форсайт Вижн4, Инк. |
Стабильные и растворимые составы ингибиторов рецепторных тирозинкиназ и способы их получения
|
|
MA40454B1
(fr)
|
2014-08-20 |
2020-01-31 |
Samumed Llc |
Gamma-dicétones pour le traitement et la prévention des rides et du vieillissement de la peau
|
|
WO2016040181A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040180A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040190A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
|
WO2016040184A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040185A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof
|
|
WO2016040188A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040182A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-1h-imidazo[4,5-c]pyridine and therapeutic uses thereof
|
|
WO2016040193A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
|
BR112017007466B1
(pt)
|
2014-10-13 |
2021-03-02 |
Ferrosan Medical Devices A/S |
método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca
|
|
CN110478119B
(zh)
|
2014-11-10 |
2022-04-15 |
弗赛特影像4股份有限公司 |
可膨胀药物递送装置和使用方法
|
|
RU2705905C2
(ru)
|
2014-12-24 |
2019-11-12 |
Ферросан Медикал Дивайсиз А/С |
Шприц для удерживания и смешивания первого и второго веществ
|
|
US10010502B2
(en)
|
2015-05-19 |
2018-07-03 |
Amorphex Therapeutics Llc |
Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation
|
|
CA2986981A1
(en)
|
2015-07-03 |
2017-01-12 |
Ferrosan Medical Devices A/S |
Syringe for mixing two components and for retaining a vacuum in a storage condition
|
|
WO2017023989A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
WO2017023987A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
|
US10463651B2
(en)
|
2015-08-03 |
2019-11-05 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-indazoles and therapeutic uses thereof
|
|
US10383861B2
(en)
|
2015-08-03 |
2019-08-20 |
Sammumed, LLC |
3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
|
US10519169B2
(en)
|
2015-08-03 |
2019-12-31 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
WO2017023984A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
|
WO2017023988A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
WO2017024004A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
US10166218B2
(en)
|
2015-08-03 |
2019-01-01 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
|
WO2017023980A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
|
US10350199B2
(en)
|
2015-08-03 |
2019-07-16 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
|
WO2017023972A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
WO2017024003A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
US10226453B2
(en)
|
2015-08-03 |
2019-03-12 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
WO2017023996A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
|
WO2017023986A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-indol-2-yl)-1h-indazoles and therapeutic uses thereof
|
|
US10329309B2
(en)
|
2015-08-03 |
2019-06-25 |
Samumed, Llc |
3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
MX380092B
(es)
|
2015-11-06 |
2025-03-11 |
Samumed Llc |
Tratamiento de la osteoartritis.
|
|
WO2017087902A1
(en)
|
2015-11-20 |
2017-05-26 |
Forsight Vision4, Inc. |
Porous structures for extended release drug delivery devices
|
|
CN113017981B
(zh)
|
2016-04-05 |
2023-07-25 |
弗赛特影像4股份有限公司 |
药物递送装置
|
|
AR108325A1
(es)
|
2016-04-27 |
2018-08-08 |
Samumed Llc |
Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
|
|
AR108326A1
(es)
|
2016-04-27 |
2018-08-08 |
Samumed Llc |
Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
|
|
MX390577B
(es)
|
2016-06-01 |
2025-03-20 |
Samumed Llc |
Proceso de preparación de n-(5-(3-(7-(3-fluorofenil)-3h-imidazo[4,5-c]piridin-2-il)-1h-indazol-5-il)piridin-3-il)-3-metilbutanamida.
|
|
JP2019535672A
(ja)
|
2016-10-21 |
2019-12-12 |
サミュメッド リミテッド ライアビリティ カンパニー |
インダゾール−３−カルボキサミドの使用方法およびｗｎｔ／β−カテニンシグナル伝達経路阻害剤としてのそれらの使用
|
|
MA46696A
(fr)
|
2016-11-07 |
2019-09-11 |
Samumed Llc |
Formulations injectables à dose unique prêtes à l'emploi
|
|
US10604514B2
(en)
|
2017-10-19 |
2020-03-31 |
Samumed, Llc |
6-(5-membered heteroaryl)isoquinolin-3-yl carboxamides and preparation and use thereof
|
|
WO2019084497A1
(en)
|
2017-10-27 |
2019-05-02 |
Samumed, Llc |
6- (HETEROARYL AND ARYL WITH 6 CHAINS) ISOQUINOLIN-3-YL CARBOXAMIDES, THEIR PREPARATION AND THEIR USE
|
|
WO2019084496A1
(en)
|
2017-10-27 |
2019-05-02 |
Samumed, Llc |
6- (HETEROARYL 5-CHAIN) ISOQUINOLIN-3-YL- (HETEROARYL 5-CHAIN) CARBOXAMIDES, PREPARATION AND USE
|
|
US10703748B2
(en)
|
2017-10-31 |
2020-07-07 |
Samumed, Llc |
Diazanaphthalen-3-yl carboxamides and preparation and use thereof
|
|
CN111655206B
(zh)
|
2017-11-21 |
2022-10-14 |
弗赛特影像4股份有限公司 |
用于可扩展端口递送系统的流体交换装置及使用方法
|
|
EP3755696B1
(de)
|
2018-02-23 |
2023-04-05 |
BioSplice Therapeutics, Inc. |
5-heteroarylsubstituierte indazol-3-carboxamide sowie herstellung und verwendung davon
|
|
EP4321182A3
(de)
|
2018-05-09 |
2024-05-29 |
Ferrosan Medical Devices A/S |
Verfahren zur herstellung einer hämostatischen zusammensetzung
|
|
WO2019241540A1
(en)
|
2018-06-15 |
2019-12-19 |
Samumed, Llc |
Indazole containing macrocycles and therapeutic uses thereof
|
|
WO2020006429A1
(en)
|
2018-06-28 |
2020-01-02 |
Hepatikos Therapeutics, Llc |
Ask1 isoindolin-1-one inhibitors and methods of use thereof
|
|
WO2020150545A1
(en)
|
2019-01-17 |
2020-07-23 |
Samumed, Llc |
Pyrazole derivatives as modulators of the wnt/b-catenin signaling pathway
|
|
BR112022007332A2
(pt)
|
2019-10-24 |
2022-07-05 |
E Labombard Denis |
Dispositivo ocular, métodos, composição, caixa para conter e dispensar um dispositivo ocular e kit
|
|
WO2021168341A1
(en)
|
2020-02-21 |
2021-08-26 |
Samumed, Llc |
Solid forms of 1-(5-(3-(7-(3-fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)-n,n-dimethylmethanamine
|
|
WO2023030435A1
(en)
|
2021-09-01 |
2023-03-09 |
Shanghai Qisheng Biological Preparation Co., Ltd. |
Cartilage regeneration using injectable, in situ polymerizable collagen compositions containing chondrocytes or stem cells
|
|
WO2023064349A1
(en)
|
2021-10-12 |
2023-04-20 |
Biosplice Therapeutics, Inc. |
1h-pyrrolo[2,3-b]pyridines as dyrk1a inhibitors
|
|
CA3234831A1
(en)
|
2021-10-12 |
2023-04-20 |
Biosplice Therapeutics, Inc. |
Pyrrolo[2,1-f][1,2,4]triazines derivatives as inhibitors of dyrk1a
|
|
US12304974B2
(en)
|
2021-12-28 |
2025-05-20 |
Shanghai Qisheng Biological Preparation Co., Ltd. |
Hyaluronic acid-collagen copolymer compositions and medical applications thereof
|
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|
|
EP4543886A1
(de)
|
2022-06-23 |
2025-04-30 |
BioSplice Therapeutics, Inc. |
4-alkoxypyrrolo[2,1-f [1,2,4)triazine und ihre herstellung und verwendung
|
|
EP4611890A1
(de)
|
2022-11-03 |
2025-09-10 |
BioSplice Therapeutics, Inc. |
4-aminopyrrolo[2,1-f [1,2,4)triazine und ihre herstellung und verwendung
|
|
WO2024211797A1
(en)
|
2023-04-07 |
2024-10-10 |
Biosplice Therapeutics, Inc. |
Pyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereof
|
|
US20250206746A1
(en)
|
2023-12-22 |
2025-06-26 |
Biosplice Therapeutics, Inc. |
4-alkoxypyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereof
|
|
US20250340575A1
(en)
|
2024-05-03 |
2025-11-06 |
Biosplice Therapeutics, Inc. |
4-aminopyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereof
|